The trajectory of Sildenafil presents a intricate picture for investors. While the initial introduction generated substantial gains, the expiration of its patent opened the floodgates to off-brand versions, https://altbookmark.com/story23596978/sildenafil-and-big-pharma-a-volatile-investment